ラテンアメリカの高度創傷ケア市場 – 2030年までの予測

出版社 MarketsandMarkets
出版年月 2025年4月

LATAM Advanced Wound Care Market – Forecast To 2030

ラテンアメリカの高度創傷ケア市場 – 製品（フォーム、ハイドロコロイド、フィルム、アルギン酸塩、コラーゲン）、創傷タイプ（慢性（糖尿病性足潰瘍、褥瘡）、急性（外科、火傷））、エンドユーザー（病院、クリニック、ASC）、地域別 – 2030年までの予測
Latin America Advanced Wound Care Market by Product (Foam, Hydrocolloid, Film, Alginate, Collagen), Wound Type (Chronic (Diabetic Foot Ulcers, Pressure Ulcers), Acute (Surgical, Burns)), End User (Hospitals, Clinics, ASCs), Region – Forecast to 2030

The LATAM advanced wound care market is projected to reach USD 498.2 million by 2030 from USD 312.8 million in 2025, at a CAGR of 9.8% during the forecast period.

ラテンアメリカ（LATAM）の高度創傷ケア市場は、予測期間中に9.8%のCAGRで成長し、2025年の3億1,280万米ドルから2030年には4億9,820万米ドルに達すると予測されています。

The growth of the LATAM advanced wound care market is primarily driven by the rising incidence of chronic conditions that hinder wound healing, the growing geriatric population, and the emergence of age-related syndromes. The increasing prevalence of diabetes and obesity further accelerates this trend. Moreover, the surge in burn injuries, trauma cases, and road accidents has increased the demand for effective advanced wound care solutions. However, the high cost of advanced wound care products and the potential risks associated with their use pose challenges to market expansion. Despite these barriers, the ongoing development of healthcare infrastructure and the adoption of advanced technologies present substantial opportunities for market growth.

ラテンアメリカにおける高度創傷ケア市場の成長は、創傷治癒を阻害する慢性疾患の発症率上昇、高齢化人口の増加、そして加齢性症候群の出現が主な要因となっています。糖尿病と肥満の増加もこの傾向をさらに加速させています。さらに、火傷、外傷、交通事故の急増も、効果的な高度創傷ケアソリューションへの需要を高めています。しかしながら、高度創傷ケア製品の高コストと使用に伴う潜在的なリスクは、市場拡大の課題となっています。こうした障壁があるにもかかわらず、医療インフラの継続的な発展と先進技術の導入は、市場成長の大きな機会を生み出しています。

ラテンアメリカの高度創傷ケア市場 – 2030年までの予測
latin-america-advanced-wound-care-market-Ecosystem

The leading players operating in the LATAM advanced wound care market are Solventum (US), Smith+Nephew (UK), Cardinal Health (US), B. Braun SE (Germany), Mölnlycke AB (Sweden), Essity Aktiebolag (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Coloplast Group (Denmark), Integra LifeSciences Corporation (US), MATIV HOLDINGS, INC. (US), Owens & Minor (US), and AVERY DENNISON CORPORATION (US).

This report provides insights into the following points:

  • Analysis of Key DROCs: Drivers (the increasing incidence of chronic conditions impairing wound healing, the rising incidence of burn injuries, the growing number of trauma cases and road accidents); restraints (high cost of advanced wound care products, risk associated with advanced wound care products); opportunities (expansion of healthcare infrastructure & uptake of advanced technologies and universal health coverage); and challenges (shortage of skilled healthcare professionals, complications associated with delayed diagnosis, and limited awareness)
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the LATAM advanced wound care market
  • Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the LATAM advanced wound care market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the LATAM advanced wound care market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.